SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM), a supplier of microfluidic systems for growth markets in the life science and agricultural biotechnology industries, today announced the pricing of its offering of $175 million aggregate principal amount of its 2.75% convertible senior notes due 2034 (the “notes”) in an underwritten public offering. Fluidigm has granted the underwriter of the notes a 30-day option to purchase up to an additional $26.25 million aggregate principal amount of the notes to cover over-allotments, if any. The offering is expected to close on or around February 4, 2014, subject to satisfaction of customary closing conditions.
Help employers find you! Check out all the jobs and post your resume.
